Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01672814 · ClinicalTrials.gov registry record · Phase 3
Microwave Treatment and Corneal Collagen Crosslinking for Keratoconus
A Phase 3 study, sponsored by Cornea and Laser Eye Institute.
- Completed
- Registry status
- Phase 3
- Development phase
- 3
- Enrollment target
NCT01672814 is a Phase 3 study that has completed, run by Cornea and Laser Eye Institute. The registered enrollment target is 3 participants.
The verdict
NCT01672814, a Phase 3 study, has completed, sponsored by Cornea and Laser Eye Institute.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study compares the outcomes of the Vedera KXS procedure (a microwave-based procedure, also known as Keraflex) combined with corneal collagen crosslinking to corneal collagen crosslinking alone for the treatment of keratoconus. The goal is to improve corneal shape in patients with keratoconus.
Interventions
- DRUG riboflavin ophthalmic solution
- DEVICE Vedera KXS Microwave System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2012-08 |
| Est. Completion | 2017-06-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01672814
The ClinicalTrials.gov registry entry for NCT01672814 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cornea and Laser Eye Institute, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which riboflavin ophthalmic solution is the first listed.
NCT01672814 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01672814 about?
NCT01672814 is a clinical study titled "Microwave Treatment and Corneal Collagen Crosslinking for Keratoconus". This study compares the outcomes of the Vedera KXS procedure (a microwave-based procedure, also known as Keraflex) combined with corneal collagen crosslinking to corneal collagen crosslinking alone for the treatment of keratoconus. The goal is to improve corneal shape in patients with keratoconus.
What is the current status of trial NCT01672814?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3 participants. The study started on 2012-08. Estimated completion is 2017-06-01.
What interventions are being tested in trial NCT01672814?
The interventions under investigation include: riboflavin ophthalmic solution (DRUG), Vedera KXS Microwave System (DEVICE).
Who is sponsoring clinical trial NCT01672814?
This trial is sponsored by Cornea and Laser Eye Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.